Ziemlewicz Timothy J, Binkley Neil, Pickhardt Perry J
Department of Radiology, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin.
Department of Radiology, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin.
J Am Coll Radiol. 2015 Oct;12(10):1036-41. doi: 10.1016/j.jacr.2015.04.018.
For patients undergoing CT colonography (CTC), the screening presents an opportunity for concurrent osteoporosis screening, without increasing radiation exposure or the time involved for the patient, using proximal femur quantitative CT-CT x-ray absorptiometry (QCT-CTXA).
This cohort included 129 women and 112 men (mean age: 60.1 ± 8.2 years; range: 50-95 years) who underwent CTC between March 2013 and September 2014. Areal bone mineral density (BMD; g/cm(2)), and resultant left femoral neck T-score, was prospectively measured on the supine CT series. QCT results were reported with the CTC. Chart review evaluated whether the patients were eligible for BMD screening according to guidelines from the US Preventive Services Task Force and the National Osteoporosis Foundation guidelines; whether they had undergone prior BMD testing; and whether QCT results changed patient management.
Overall, 68.0% (164 of 241) of patients from this cohort had not previously undergone BMD screening. According to the National Osteoporosis Foundation guidelines, 44.0% (106 of 241) of patients were eligible for screening. T-scores within the osteopenic and osteoporotic range were detected in 32.3% (78 of 241) and 5.0% (12 of 241) of patients, respectively. Of these patients with low BMD, 66.7% (60 of 90) either had not previously undergone screening or were eligible for BMD testing. Reporting of QCT-CTXA T-scores altered management in 9 patients (3.7%) who had low BMD.
Maximizing the pre-existing value from imaging studies is crucial in the current era of health care reform. We demonstrate that colorectal and osteoporosis screening can be combined at CT examination, adding clinical and likely economic value.
对于接受CT结肠成像(CTC)的患者,该筛查提供了一个同时进行骨质疏松症筛查的机会,无需增加辐射暴露或患者所花费的时间,采用近端股骨定量CT-CTX线吸收法(QCT-CTXA)。
该队列包括2013年3月至2014年9月期间接受CTC的129名女性和112名男性(平均年龄:60.1±8.2岁;范围:50 - 95岁)。在仰卧位CT系列上前瞻性测量面积骨密度(BMD;g/cm²)以及由此得出的左股骨颈T值。QCT结果随CTC报告。病历审查评估患者是否根据美国预防服务工作组和国家骨质疏松基金会指南符合BMD筛查条件;他们是否曾接受过先前的BMD检测;以及QCT结果是否改变了患者的治疗管理。
总体而言,该队列中68.0%(241名中的164名)患者此前未接受过BMD筛查。根据国家骨质疏松基金会指南,44.0%(241名中的106名)患者符合筛查条件。分别在32.3%(241名中的78名)和5.0%(241名中的12名)患者中检测到骨量减少和骨质疏松范围内的T值。在这些BMD低的患者中,66.7%(90名中的60名)此前未接受过筛查或符合BMD检测条件。QCT-CTXA T值的报告改变了9名(3.7%)BMD低的患者的治疗管理。
在当前医疗保健改革时代,最大化现有影像学研究的价值至关重要。我们证明结肠直肠癌和骨质疏松症筛查可在CT检查时结合进行,增加临床价值并可能具有经济价值。